• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

急性脑卒中期间局部脑重组组织型纤溶酶原激活剂浓度。

Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke.

机构信息

Department of Neurology, University Hospital Würzburg, Würzburg, Germany.

Department of Neuroradiology, University Hospital Würzburg, Würzburg, Germany.

出版信息

JAMA Neurol. 2021 May 1;78(5):615-617. doi: 10.1001/jamaneurol.2021.0065.

DOI:10.1001/jamaneurol.2021.0065
PMID:33683294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7941250/
Abstract

This study evaluates concentrations of local cerebral recombinant tissue plasminogen activator during mechanical thrombectomy treatment in acute stroke.

摘要

本研究评估了急性脑卒中机械血栓切除术中局部脑重组组织型纤溶酶原激活剂的浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b57c/7941250/7aacbc85946d/jamaneurol-e210065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b57c/7941250/7aacbc85946d/jamaneurol-e210065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b57c/7941250/7aacbc85946d/jamaneurol-e210065-g001.jpg

相似文献

1
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke.急性脑卒中期间局部脑重组组织型纤溶酶原激活剂浓度。
JAMA Neurol. 2021 May 1;78(5):615-617. doi: 10.1001/jamaneurol.2021.0065.
2
Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
Stroke. 2014 Dec;45(12):e304. doi: 10.1161/STROKEAHA.114.007363. Epub 2014 Oct 23.
3
Breaking up is hard to do: tenecteplase in acute stroke.分手不易：急性卒中中的替奈普酶
Lancet Neurol. 2015 Apr;14(4):343-5. doi: 10.1016/S1474-4422(15)70036-0. Epub 2015 Feb 26.
4
Door-to-needle times in acute ischemic stroke: how low can we go?急性缺血性卒中的门针时间：我们能降至多低？
Neurology. 2012 Jul 24;79(4):296-7. doi: 10.1212/WNL.0b013e31825d602e. Epub 2012 May 23.
5
Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".Chao等人就“标准剂量静脉注射组织型纤溶酶原激活剂治疗中风优于低剂量”这篇文章所写的信。
Stroke. 2014 Dec;45(12):e303. doi: 10.1161/STROKEAHA.114.007340. Epub 2014 Oct 23.
6
Thrombolytic therapy in a patient with acute ischemic stroke caused by aortic dissection.主动脉夹层所致急性缺血性卒中患者的溶栓治疗
Clin Neurol Neurosurg. 2010 Oct;112(8):695-6. doi: 10.1016/j.clineuro.2010.03.021. Epub 2010 Apr 27.
7
rt-PA for ischaemic stroke: what will the next question be?用于缺血性中风的重组组织型纤溶酶原激活剂：下一个问题会是什么？
Lancet. 2012 Jun 23;379(9834):2320-1. doi: 10.1016/S0140-6736(12)60822-8. Epub 2012 May 23.
8
Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.膜联蛋白 A2：溶栓性脑卒中治疗的组织型纤溶酶原激活物放大器。
Stroke. 2010 Oct;41(10 Suppl):S54-8. doi: 10.1161/STROKEAHA.110.596106.
9
Wake-up to wake-up stroke!清醒至清醒期卒中！
Can J Neurol Sci. 2014 Mar;41(2):137-8. doi: 10.1017/s0317167100016462.
10
[Thrombolytic therapy in acute ischemic stroke: present and future].[急性缺血性卒中的溶栓治疗：现状与未来]
No Shinkei Geka. 2003 Mar;31(3):249-60.

引用本文的文献

1
A nomogram predictive model for factors influencing prognosis of acute ischemic stroke patients after intravenous thrombolysis.静脉溶栓治疗后急性缺血性脑卒中患者预后影响因素的列线图预测模型
Am J Transl Res. 2025 Apr 15;17(4):2957-2966. doi: 10.62347/MNDY3660. eCollection 2025.
2
The role of nanomaterials in revolutionizing ischemic stroke treatment: Current trends and future prospects.纳米材料在缺血性中风治疗变革中的作用：当前趋势与未来前景
iScience. 2024 Nov 15;27(12):111373. doi: 10.1016/j.isci.2024.111373. eCollection 2024 Dec 20.
3
Ischemia/reperfusion injury in acute human and experimental stroke: focus on thrombo-inflammatory mechanisms and treatments.
急性人类及实验性中风中的缺血/再灌注损伤：聚焦于血栓炎症机制与治疗
Neurol Res Pract. 2024 Nov 25;6(1):57. doi: 10.1186/s42466-024-00355-y.
4
Protective Effect of Protocatechuic Aldehyde on Cerebral Ischemia/Reperfusion Injury in Rats through Blood-Brain Barrier Protection.原儿茶醛通过血脑屏障保护作用对大鼠脑缺血再灌注损伤的保护作用。
Bull Exp Biol Med. 2024 Oct;177(6):763-769. doi: 10.1007/s10517-024-06264-z. Epub 2024 Oct 26.
5
Nanoparticle Formulations of Antioxidants for the Management of Oxidative Stress in Stroke: A Review.用于中风氧化应激管理的抗氧化剂纳米颗粒制剂：综述
Biomedicines. 2023 Nov 9;11(11):3010. doi: 10.3390/biomedicines11113010.
6
assessment of histotripsy-induced changes in catheter-directed thrombolytic delivery.组织超声碎裂术对导管定向溶栓给药影响的评估
Front Physiol. 2023 Jun 28;14:1225804. doi: 10.3389/fphys.2023.1225804. eCollection 2023.
7
Distinct Alterations in Oxygenation, Ion Composition and Acid-Base Balance in Cerebral Collaterals During Large-Vessel Occlusion Stroke.在大血管闭塞性中风期间，脑侧支中的氧合、离子组成和酸碱平衡存在明显改变。
Clin Neuroradiol. 2023 Dec;33(4):973-984. doi: 10.1007/s00062-023-01296-w. Epub 2023 Jun 7.
8
Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion.血管活性可溶性内皮下蛋白：一种提示大脑大血管阻塞再灌注的新型生物标志物。
Cells. 2023 Jan 11;12(2):288. doi: 10.3390/cells12020288.
9
Blockade of Platelet Glycoprotein Ibα Augments Neuroprotection in Orai2-Deficient Mice during Middle Cerebral Artery Occlusion.血小板糖蛋白 Ibα 阻断增强 Orai2 缺陷型小鼠大脑中动脉闭塞期间的神经保护作用。
Int J Mol Sci. 2022 Aug 22;23(16):9496. doi: 10.3390/ijms23169496.
10
Regulation and Release of Vasoactive Endoglin by Brain Endothelium in Response to Hypoxia/Reoxygenation in Stroke.脑内皮细胞在中风缺氧/复氧反应中对血管活性内皮糖蛋白的调节和释放。
Int J Mol Sci. 2022 Jun 25;23(13):7085. doi: 10.3390/ijms23137085.